RESEARCH UPDATE:
Probiotics For The Treatment of Infants
Recent research has compared the effect of B. infantis compared to L. acidophilus on known inflammatory markers in both mature and immature intestinal tissues. When the researchers tested the effects of secretions from B. infantis and L. acidophilus separately on fetal intestinal cells, they found that those from B. infantis alone showed a greater ability to reduce inflammation.
Media coverage last week highlighted some outstanding results coming out of Nepean hospital using these probiotic protocols, which has been so significant they are now being implemented across the country.
BioMedica has long been an advocate for the use of B. infantis in maintaining the gastrointestinal health of infants under 3 years of age. NeoCare is a pure, low allergenic and hygienic source of B. infantis readily available in single serve sachets for practitioner only prescribing. That means ” ask and I can organise it for you”